Chemical exposure-induced systemic fibrosing disorders: Novel insights into systemic sclerosis etiology and pathogenesis
Authors:
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 50 (6) , 1226-1237
Abstract
No abstract availableKeywords
This publication has 191 references indexed in Scilit:
- Understanding Nephrogenic Systemic FibrosisInternational Journal of Nephrology, 2012
- Mechanisms of fibrosis: therapeutic translation for fibrotic diseaseNature Medicine, 2012
- Role of Endothelial-Mesenchymal Transition (EndoMT) in the Pathogenesis of Fibrotic DisordersThe American Journal of Pathology, 2011
- Regulation of endothelial cell plasticity by TGF-βCell and tissue research, 2011
- Scraping fibrosis: Expressway to the core of fibrosisNature Medicine, 2011
- Protein kinase Cδ and c‐Abl kinase are required for transforming growth factor β induction of endothelial–mesenchymal transition in vitroArthritis & Rheumatism, 2011
- Immunogenetic risk and protective factors for the development of L‐tryptophan–associated eosinophilia–myalgia syndrome and associated symptomsArthritis Care & Research, 2009
- Induction of the expression of profibrotic cytokines and growth factors in normal human peripheral blood monocytes by gadolinium contrast agentsArthritis & Rheumatism, 2009
- Immunostimulatory activity of haptenated proteinsProceedings of the National Academy of Sciences, 2009
- Scleroderma-like Fibrosing DisordersRheumatic Disease Clinics of North America, 2008